• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIU Huanyun, LI Lufeng, XU Chunxin, DENG Mengyang, ZHAO Xiaohui. Preparation of pitavastatin-loaded poly lactic-co-glycolic acid nanoparticles and their effects on proliferation of endothelial progenitor cells[J]. Journal of China Pharmaceutical University, 2016, 47(2): 166-170. DOI: 10.11665/j.issn.1000-5048.20160207
Citation: LIU Huanyun, LI Lufeng, XU Chunxin, DENG Mengyang, ZHAO Xiaohui. Preparation of pitavastatin-loaded poly lactic-co-glycolic acid nanoparticles and their effects on proliferation of endothelial progenitor cells[J]. Journal of China Pharmaceutical University, 2016, 47(2): 166-170. DOI: 10.11665/j.issn.1000-5048.20160207
shu

Preparation of pitavastatin-loaded poly lactic-co-glycolic acid nanoparticles and their effects on proliferation of endothelial progenitor cells

More Information
    Graphical Abstract
    • Abstract
  • The objectives of this study were to prepare pitavastatin-loaded poly lactic-co-glycolic acid nanoparticles(PLGA), to characterize their pharmaceutical properties, to conduct in vitro drug-release from the nanoparticles, and to observe the effects on the proliferation of endothelial progenitor cells. Both pitavastatin-loaded PLGA and blank PLGA nanoparticles were prepared using emulsion-solvent diffusion method with PLGA being carrier materials. Morphology of the nanoparticles was observed by scanning electron microscopy(SEM), and particle size was analyzed by laser nanometer particle size analyzer. The drug loading and encapsulation efficiency were assayed using high-performance liquid phase. Impact of blank and pitavastatin-loaded nanoparticles on the viability of endothelial progenitor cells was investigated by CCK8 method. Pitavastatin-loaded PLGA nanoparticles exhibited the structure with spherical shape, smooth surface and average diameter of(230. 1±45)nm. The drug loading capacity and encapsulation efficiency were(10. 00±1. 83)% and(35. 54±5. 40)%, respectively. In vitro sustained-release of pitavastatin from the nanoparticles was found. The blank PLGA nanoparticles had no effect on the viability of the endothelial progenitor cells in different concentrations. Compared with pitavastatin group, pitavastatin-loaded nanoparticles(0. 01 μmol/L, 0. 1 μmol/L)had more effects on the proliferation of endothelial progenitor cells. In conclusion, emulsion-solvent diffusion method is applicable in preparation of pitavastatin-loaded PLGA nanoparticles with good shape and sustained-release of interest. Pitavastatin-loaded nanoparticles could significantly improve proliferation of the endothelial progenitor cells.
    • FullText(HTML)
    • References (11)
  • [1]
    Catapano AL. Pitavastatin-pharmacological profile from early phase studies[J].Atheroscler Suppl,2010,11(3):3-7.
    [2]
    Betteridge J.Pitavastatin-results from phase III & IV[J].Atheroscler Suppl,2010,11(3):8-14.
    [3]
    Moghimi SM,Hunter AC,Murray JC.Nanomedicine:current status and future prospects[J].FASEB J,2005,19(3):311-330.
    [4]
    Kubo M,Egashira K,Inoue T,et al.Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium[J].Arterioscler Thromb Vasc Biol,2009,29(6):796-801.
    [5]
    Katsuki S,Matoba T,Nakashiro S,et al.Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes[J].Circulation,2014,129(8):896-906.
    [6]
    Malathi S,Nandhakumar P,Pandiyan V,et al.Novel PLGA-based nanoparticles for the oral delivery of insulin[J].Int J Nanomedicine,2015,10:2207-2218.
    [7]
    Vasir JK,Labhasetwar V.Biodegradable nanoparticles for cytosolic delivery of therapeutics[J].Adv Drug Deliv Rev,2007,59(8):718-728.
    [8]
    Suarez S,Almutairi A,Christman KL.Micro- and nanoparticles for treating cardiovascular disease[J].Biomater Sci,2015,3(4):564-580.
    [9]
    Matoba T,Egashira K.Nanoparticle-mediated drug delivery system for cardiovascular disease[J].Int Heart J,2014,55(4):281-286.
    [10]
    Oda S, Nagahama R, Nakano K, et al. Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries(therapeutic arteriogenesis)in a rabbit model of chronic hind limb ischemia[J].J Vasc Surg,2010,52(2):412-420.
    [11]
    Xu YX,Luan TZ,Shi PW,et al.Effects of pitavastatin on number and activity of endothelial progenitor cells from umbilical vein blood[J].Prog Mod Biomed(现代生物医学进展),2014,14(6):1053-1056.
    • Related Articles

  • Related Articles

    [1]ZHANG Wanyue, LIU Wei, XU Hang, GAO Xiangdong. Advanced structure analysis and structure-activity relationship of polysaccharide SGP-2 from Sarcandra glabra[J]. Journal of China Pharmaceutical University, 2021, 52(5): 630-635. DOI: 10.11665/j.issn.1000-5048.20210517
    [2]CHEN Shumin, HUANG Wenlong, HU Guoqiang. Synthesis and antitumor activity of fluoroquinolone C-3 isostere V: ciprofloxacin acylhydrazone derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(2): 161-164. DOI: 10.11665/j.issn.1000-5048.20140205
    [3]LIU Haomiao, HU Xiaowen, ZHOU Jinpei, ZHANG Huibin. Advances of G protein coupled receptor 119 agonists and their structure-activity relationship[J]. Journal of China Pharmaceutical University, 2013, 44(1): 11-19. DOI: 10.11665/j.issn.1000-5048.20130102
    [4]2D-QSAR and HQSAR study on quantitative structure-activity relationship of 6-O-aryl ketolides derivatives[J]. Journal of China Pharmaceutical University, 2010, 41(3): 208-215.
    [5]ZHENG Kai-bo, SUN Cheng-bin, MAO Hai-li, YANG Zai-bo. Progress in the research of chemical structural modification of ursolic acid and structure-activity relationship[J]. Journal of China Pharmaceutical University, 2009, 40(6): 580-584.
    [6]Studies on the Quantitative Structure activity Relationship of the Quinolone Antibacterials Against Mycobacteria:Effect of Structural Changes at C 7[J]. Journal of China Pharmaceutical University, 1999, (1): 18-20.
    [7]Synthesis and Anesthetic Activity of 3-Methyl Fentanyl Derivatives[J]. Journal of China Pharmaceutical University, 1993, (5): 257-263.
    [8]Synthesis, Analgesic Activity and Structure-Activity Relationship of 4-N-Cyclohexyl Analogs of Some Fentanyl Derivatives[J]. Journal of China Pharmaceutical University, 1993, (3): 139-144.
    [9]Structural-Activity Relations Study on the Derivatives of 3,4-Dimethoxyphenylenediamine[J]. Journal of China Pharmaceutical University, 1992, (4): 217-220.
    [10]DETERMINATION OF HYDROLYSIS RATE AND PRELIMINARY STRUCTURE-ACTIVITY RELATIONSHIP OF THIOHYDANTOIN DERIVATIVES[J]. Journal of China Pharmaceutical University, 1989, (4): 199-202.

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：292707

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return